TABLE 3

Summary of Cost-effectiveness Estimates by Health Condition and Perspective

Health Conditions
BPD or CLDCHDHealthyPretermPreterm With BPD or CLDPreterm With Risk FactorsOther Risk Factorsa
Payer perspective
No. estimates 10 22 14
ICER (minimum) 3984 9837 Dominant 5188 12 653 177 Dominant
ICER (maximum) 40 036 139 051 148 205 791 265 111 171 169 103 560 792
Proportion of estimates’ CE <$50 000 per QALY 1.00 0.80 0.67 0.86 0.75 0.79 0.50 Proportion of estimates’ CE <$100 000 per QALY 1.00 0.90 0.67 0.86 0.75 0.86 0.50
Proportion of estimates’ CE <$200 000 per QALY 1.00 1.00 1.00 0.91 1.00 1.00 0.75 Societal perspective No. estimates 23 ICER (minimum) 23 469 Dominant Dominant Dominant 15 779 18 041 Dominant ICER (maximum) 23 469 176.749 145 903 2 526 203 116 573 522 514 Dominant Proportion of estimates’ CE <$50 000 per QALY 1.00 0.63 0.67 0.43 0.67 0.33 1.00
Proportion of estimates’ CE <$100 000 per QALY 1.00 0.63 0.83 0.48 0.67 0.67 1.00 Proportion of estimates’ CE <$200 000 per QALY 1.00 1.00 1.00 0.52 1.00 0.67 1.00
Health Conditions
BPD or CLDCHDHealthyPretermPreterm With BPD or CLDPreterm With Risk FactorsOther Risk Factorsa
Payer perspective
No. estimates 10 22 14
ICER (minimum) 3984 9837 Dominant 5188 12 653 177 Dominant
ICER (maximum) 40 036 139 051 148 205 791 265 111 171 169 103 560 792
Proportion of estimates’ CE <$50 000 per QALY 1.00 0.80 0.67 0.86 0.75 0.79 0.50 Proportion of estimates’ CE <$100 000 per QALY 1.00 0.90 0.67 0.86 0.75 0.86 0.50
Proportion of estimates’ CE <$200 000 per QALY 1.00 1.00 1.00 0.91 1.00 1.00 0.75 Societal perspective No. estimates 23 ICER (minimum) 23 469 Dominant Dominant Dominant 15 779 18 041 Dominant ICER (maximum) 23 469 176.749 145 903 2 526 203 116 573 522 514 Dominant Proportion of estimates’ CE <$50 000 per QALY 1.00 0.63 0.67 0.43 0.67 0.33 1.00
Proportion of estimates’ CE <$100 000 per QALY 1.00 0.63 0.83 0.48 0.67 0.67 1.00 Proportion of estimates’ CE <$200 000 per QALY 1.00 1.00 1.00 0.52 1.00 0.67 1.00

All ICERs are reported in 2017 USDs per QALY. CE, cost-effective.

a

Cystic fibrosis, major risk factors (chronological age <10 wk at beginning of RSV season [being born during first 10 wk of the season], school-aged siblings, and day care attendance), and minor risk factors (mother smoking during pregnancy and male sex).

Close Modal